HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Francesca Ferrua Selected Research

Pioglitazone (Actos)

1/2016Pioglitazone as a novel therapeutic approach in chronic granulomatous disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Francesca Ferrua Research Topics

Disease

15Severe combined immunodeficiency due to adenosine deaminase deficiency
02/2024 - 01/2009
13Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome)
02/2024 - 01/2009
6Wiskott-Aldrich Syndrome
04/2024 - 08/2013
4Infections
01/2021 - 11/2009
2Mucopolysaccharidosis I (Hurler Syndrome)
05/2024 - 11/2021
2X-Linked Combined Immunodeficiency Diseases (X Linked Severe Combined Immunodeficiency)
12/2023 - 09/2023
2Neutropenia
01/2023 - 01/2022
2Chronic Granulomatous Disease
11/2022 - 01/2016
2Type 1 Hyper-IgM Immunodeficiency Syndrome
01/2021 - 01/2019
2Metachromatic Leukodystrophy (Sulfatide Lipidosis)
12/2019 - 01/2018
2Hemorrhage
05/2019 - 01/2019
1Kyphosis
05/2024
1Paralysis (Palsy)
02/2022
1Immune System Diseases (Immune Disorders)
01/2022
1Tuberculosis (Tuberculoses)
01/2021
1Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome)
01/2021
1Cryptorchidism (Undescended Testes)
01/2020
1COVID-19
01/2020
1Metabolic Diseases (Metabolic Disease)
01/2016
1Neoplasms (Cancer)
06/2011
1Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive)
11/2009
1Iron Overload
11/2009
1beta-Thalassemia (Cooley's Anemia)
11/2009
1Liver Cirrhosis (Hepatic Cirrhosis)
11/2009

Drug/Important Bio-Agent (IBA)

11Adenosine DeaminaseIBA
02/2024 - 01/2009
3Busulfan (Busulfex)FDA Link
02/2024 - 11/2009
3purineIBA
11/2017 - 01/2009
2CD40 Ligand (CD40L)IBA
09/2023 - 01/2019
2AntigensIBA
01/2021 - 11/2009
2pegademase bovine (pegADA)FDA Link
01/2020 - 11/2017
2Proteins (Proteins, Gene)FDA Link
01/2019 - 08/2013
1Biomarkers (Surrogate Marker)IBA
04/2024
1Immunoglobulin M (IgM)IBA
12/2023
1IsoantibodiesIBA
01/2023
1AutoantibodiesIBA
01/2023
12019-nCoV Vaccine mRNA-1273IBA
02/2022
1Messenger RNA (mRNA)IBA
02/2022
1COVID-19 VaccinesIBA
02/2022
1VaccinesIBA
02/2022
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
01/2022
1EmapalumabIBA
01/2021
1Immunoglobulin G (IgG)IBA
01/2021
1Monoclonal AntibodiesIBA
01/2021
1Immunoglobulins (Immunoglobulin)IBA
01/2020
1Wiskott-Aldrich Syndrome ProteinIBA
05/2019
1sofosbuvir drug combination ledipasvirIBA
12/2018
1defibrotideIBA
01/2018
1Adenosine (Adenocard)FDA LinkGeneric
11/2017
1HLA Antigens (Human Leukocyte Antigens)IBA
11/2017
1Pioglitazone (Actos)FDA Link
01/2016
1fludarabineIBA
10/2010

Therapy/Procedure

9Hematopoietic Stem Cell Transplantation
05/2024 - 01/2019
3Aftercare (After-Treatment)
05/2024 - 11/2017
2Enzyme Replacement Therapy
06/2023 - 11/2017
2Stem Cell Transplantation
11/2017 - 11/2009
1Cell Transplantation
01/2022
1Therapeutics
01/2021
1Orchiopexy
01/2020
1Platelet Transfusion (Blood Platelet Transfusions)
05/2019
1Bone Marrow Transplantation (Transplantation, Bone Marrow)
10/2010